7QY-13381-69324
3 vaccinations
3 coded responses
33 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 559 / MN
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-01-15
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Nausea, Abdominal painAdult check-in
- 2021-01-18
- 2021-01-20
- 2021-01-27
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint painsAdult check-in
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
-
2021-03-09
Survey response — day 35, dose 2MedDRA: Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Appendicitis (probably unrelated to vaccination)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-17
- 2021-05-06
- 2021-08-03
-
2021-10-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-11-01
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-06
- 2021-12-09
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-01
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-09 | Successful | Participant prefers to complete VAERS report online |
| 2022-01-28 | Successful 2022-02-01 |
Participant prefers to complete VAERS report online |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Release 5 — day 35, dose 2
Symptoms: Appendicitis (probably unrelated to vaccination)
Release 11 — 3 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release